214 related articles for article (PubMed ID: 17051139)
21. Decreased glomerular expression of agrin in diabetic nephropathy and podocytes, cultured in high glucose medium.
Yard BA; Kahlert S; Engelleiter R; Resch S; Waldherr R; Groffen AJ; van den Heuvel LP; van der Born J; Berden JH; Kröger S; Hafner M; van der Woude FJ
Exp Nephrol; 2001; 9(3):214-22. PubMed ID: 11340306
[TBL] [Abstract][Full Text] [Related]
22. Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity.
Masola V; Zaza G; Secchi MF; Gambaro G; Lupo A; Onisto M
Biochim Biophys Acta; 2014 Sep; 1843(9):2122-8. PubMed ID: 24937189
[TBL] [Abstract][Full Text] [Related]
23. High glucose-induced intestinal epithelial barrier damage is aggravated by syndecan-1 destruction and heparanase overexpression.
Qing Q; Zhang S; Chen Y; Li R; Mao H; Chen Q
J Cell Mol Med; 2015 Jun; 19(6):1366-74. PubMed ID: 25702768
[TBL] [Abstract][Full Text] [Related]
24. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
[TBL] [Abstract][Full Text] [Related]
25. The protective role of fucosylated chondroitin sulfate, a distinct glycosaminoglycan, in a murine model of streptozotocin-induced diabetic nephropathy.
Gomes CL; Leão CL; Venturotti C; Barreira AL; Guimarães G; Fonseca RJ; Fortunato RS; Mourão PA; Delgado AG; Takiya CM; Leite M
PLoS One; 2014; 9(9):e106929. PubMed ID: 25192337
[TBL] [Abstract][Full Text] [Related]
26. No change in glomerular heparan sulfate structure in early human and experimental diabetic nephropathy.
van den Born J; Pisa B; Bakker MA; Celie JW; Straatman C; Thomas S; Viberti GC; Kjellen L; Berden JH
J Biol Chem; 2006 Oct; 281(40):29606-13. PubMed ID: 16885165
[TBL] [Abstract][Full Text] [Related]
27. Heparanase and Syndecan-4 Are Involved in Low Molecular Weight Fucoidan-Induced Angiogenesis.
Haddad O; Guyot E; Marinval N; Chevalier F; Maillard L; Gadi L; Laguillier-Morizot C; Oudar O; Sutton A; Charnaux N; Hlawaty H
Mar Drugs; 2015 Oct; 13(11):6588-608. PubMed ID: 26516869
[TBL] [Abstract][Full Text] [Related]
28. Urinary heparanase activity in patients with Type 1 and Type 2 diabetes.
Rops AL; van den Hoven MJ; Veldman BA; Salemink S; Vervoort G; Elving LD; Aten J; Wetzels JF; van der Vlag J; Berden JH
Nephrol Dial Transplant; 2012 Jul; 27(7):2853-61. PubMed ID: 22187315
[TBL] [Abstract][Full Text] [Related]
29. Adult and paediatric patients with minimal change nephrotic syndrome show no major alterations in glomerular expression of sulphated heparan sulphate domains.
Wijnhoven TJ; Geelen JM; Bakker M; Lensen JF; Rops AL; Kramer AB; Navis G; van den Hoven MJ; van der Vlag J; Berden JH; Wetzels JF; van den Heuvel LP; Monnens LA; van Kuppevelt TH
Nephrol Dial Transplant; 2007 Oct; 22(10):2886-93. PubMed ID: 17526541
[TBL] [Abstract][Full Text] [Related]
30. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
[TBL] [Abstract][Full Text] [Related]
31. Peroxisome proliferator-activated receptor ɣ agonist mediated inhibition of heparanase expression reduces proteinuria.
Garsen M; Buijsers B; Sol M; Gockeln L; Sonneveld R; van Kuppevelt TH; de Graaf M; van den Born J; Kamps JAAM; van Raalte DH; van der Meer RW; Lamb HJ; Hillebrands JL; Rabelink TJ; Maciej-Hulme ML; Krenning G; Nijenhuis T; van der Vlag J
EBioMedicine; 2023 Apr; 90():104506. PubMed ID: 36889064
[TBL] [Abstract][Full Text] [Related]
32. Abnormal glomerular permeability characteristics in diabetic nephropathy: implications for the therapeutic use of low-molecular weight heparin.
Lewis EJ; Xu X
Diabetes Care; 2008 Feb; 31 Suppl 2():S202-7. PubMed ID: 18227486
[TBL] [Abstract][Full Text] [Related]
33. Involvement of human heparanase in the pathogenesis of diabetic nephropathy.
Katz A; Van-Dijk DJ; Aingorn H; Erman A; Davies M; Darmon D; Hurvitz H; Vlodavsky I
Isr Med Assoc J; 2002 Nov; 4(11):996-1002. PubMed ID: 12489489
[TBL] [Abstract][Full Text] [Related]
34. Crosstalk between tumor cells and lymphocytes modulates heparanase expression.
Theodoro TR; Matos LL; Cavalheiro RP; Justo GZ; Nader HB; Pinhal MAS
J Transl Med; 2019 Mar; 17(1):103. PubMed ID: 30922347
[TBL] [Abstract][Full Text] [Related]
35. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
[TBL] [Abstract][Full Text] [Related]
36. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
37. Decrease of heparan sulfate staining in the glomerular basement membrane in murine lupus nephritis.
van Bruggen MC; Kramers K; Hylkema MN; van den Born J; Bakker MA; Assmann KJ; Smeenk RJ; Berden JH
Am J Pathol; 1995 Mar; 146(3):753-63. PubMed ID: 7534044
[TBL] [Abstract][Full Text] [Related]
38. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
[TBL] [Abstract][Full Text] [Related]
39. Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo.
Menne J; Meier M; Park JK; Boehne M; Kirsch T; Lindschau C; Ociepka R; Leitges M; Rinta-Valkama J; Holthofer H; Haller H
Kidney Int; 2006 Oct; 70(8):1456-62. PubMed ID: 16955103
[TBL] [Abstract][Full Text] [Related]
40. HPSE-1 expression and functionality in differentiating neural cells.
Moretti M; Sinnappah-Kang ND; Toller M; Curcio F; Marchetti D
J Neurosci Res; 2006 Mar; 83(4):694-701. PubMed ID: 16429446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]